Cardiorenal benefits of sodium-glucose co-transporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in type 2 diabetes without cardiovascular and renal diseases-MedSci.cn

Cardiorenal benefits of sodium-glucose co-transporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in type 2 diabetes without cardiovascular and renal diseases

Qiu, M; Zhou, X; Zhang, M

Qiu, M (通讯作者)，Shenzhen Longhua Dist Cent Hosp, Dept Gen Med, Guanlan Ave 187, Shenzhen 518110, Peoples R China.